Canis ISSN: 2398-2942

Chondroitin sulfate

Synonym(s): Chondroitin sulphate, CS

Contributor(s): Vetstream Ltd

Introduction

Name

  • Chondroitin sulfate.

Class of drug

  • Glycosaminoglycan.
  • Nutraceutical.

Description

Storage requirements

  • Store in a dry place <25°C.
  • Keep container tightly closed.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Nutritional aid in the management of degenerative joint disease.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMed Resource.
  • Lenox C E, Lunn K F (2010) Effects of glucosamine-chondroitin sulfate supplementation on serum fructosamine concentration in healthy dogs. JAVMA 236(2), 183-186 PubMed.
  • Sauve F, Paradis M, Refsal K R, Moreau M, Beauchamp G & Dupois J (2003) Effects of oral administration of meloxicam, carprofen and a nutraceutical on thyroid function in sdogs iwth osteoarthritis. Can Vet J 44(6), 474-479 PubMed.
  • Adebowale A, Du J, Liang Z, Leslie J L & Eddington N D (2002) The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 23(6), 217-225 PubMed.
  • Canapp S O, McLaughlin R M, Hoskinson J J, Roush J K & Butine M D (2000) Scintigraphic evaluation of glucosamine HCl and chondroitin sulfate as treatment for acute synovitis in dogs. Am J Vet Res 60(12), 1552-1557 PubMed.
  • Booth D M (1998) Nutraceuticals in veterinary medicine. Part II. Safety and efficacy. Comp Contin Educ Pract Vet 20(1), 15-21.
  • Booth D M (1997) Nutraceuticals in veterinary medicine. Part I. Definitions and regulations. Comp Contin Educ Pract Vet 19(12), 1248-1255.
  • McNamara P S, Barr S C & Erb H N (1996) Hematologic, hemostatic and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 57(9), 1390-1394 PubMed.

Other sources of information

  • McIlwraith C W (1999) Should I recommend the use of oral glycosaminoglycans? Comp Contin Educ Pract Vet 21(5), 450-457.

ADDED